Is Utah Medical Stock a Good Investment?
Utah Medical Investment Advice | UTMD |
- Examine Utah Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Utah Medical's leadership team and their track record. Good management can help Utah Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Utah Medical's business and its evolving consumer preferences.
- Compare Utah Medical's performance and market position to its competitors. Analyze how Utah Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Utah Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Utah Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Utah Medical Products stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Utah Medical Products is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very Low | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Alarmed | Details | |
Analyst Consensus | Strong Sell | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
Examine Utah Medical Stock
Researching Utah Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 72.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.92. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Utah Medical Products last dividend was issued on the 14th of June 2024. The entity had 3:2 split on the 22nd of March 1993.
To determine if Utah Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Utah Medical's research are outlined below:
| Utah Medical generated a negative expected return over the last 90 days | |
| About 72.0% of the company outstanding shares are owned by institutional investors | |
| On 3rd of April 2024 Utah Medical paid $ 0.3 per share dividend to its current shareholders | |
| Latest headline from seekingalpha.com: Utah Medical Products declares 0.30 dividend |
Utah Medical Quarterly Accounts Payable |
|
Utah Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Utah Medical Products. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Utah Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 23rd of April 2024 Upcoming Quarterly Report | View | |
| 31st of March 2024 Next Fiscal Quarter End | View |
Utah Medical Analyst Ratings
Utah Medical's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Utah Medical stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Utah Medical's financials, market performance, and future outlook by experienced professionals. Utah Medical's historical ratings below, therefore, can serve as a valuable tool for investors.Know Utah Medical's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Utah Medical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Utah Medical Products backward and forwards among themselves. Utah Medical's institutional investor refers to the entity that pools money to purchase Utah Medical's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jpmorgan Chase & Co | 2023-12-31 | 63.6 K | Penn Mutual Asset Management Llc | 2023-12-31 | 53.1 K | Loomis, Sayles & Company Lp | 2023-12-31 | 44.4 K | Franklin Resources Inc | 2023-12-31 | 43.3 K | Northern Trust Corp | 2023-12-31 | 38.6 K | Bank Of New York Mellon Corp | 2023-12-31 | 36.5 K | Brandes Investment Partners & Co | 2023-12-31 | 32.8 K | Clean Yield Group Inc | 2023-12-31 | 31.7 K | Isthmus Partners Llc | 2023-12-31 | 22.7 K | Fmr Inc | 2023-12-31 | 389.7 K | T. Rowe Price Investment Management,inc. | 2023-12-31 | 269.2 K |
Utah Medical's market capitalization trends
The company currently falls under 'Small-Cap' category with a current market capitalization of 247.56 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Utah Medical's market, we take the total number of its shares issued and multiply it by Utah Medical's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
Utah Medical's profitablity analysis
Utah Medical's profitability indicators refer to fundamental financial ratios that showcase Utah Medical's ability to generate income relative to its revenue or operating costs. If, let's say, Utah Medical is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Utah Medical's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Utah Medical's profitability requires more research than a typical breakdown of Utah Medical's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | 0.14 | 0.28 | |
| Return On Capital Employed | 0.14 | 0.13 | |
| Return On Assets | 0.12 | 0.21 | |
| Return On Equity | 0.13 | 0.12 |
Determining Utah Medical's profitability involves analyzing its financial statements and using various financial metrics to determine if Utah Medical is a good buy. For example, gross profit margin measures Utah Medical's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Utah Medical's profitability and make more informed investment decisions.
The data published in Utah Medical's official financial statements usually reflect Utah Medical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Utah Medical Products. For example, before you start analyzing numbers published by Utah accountants, it's critical to develop an understanding of what Utah Medical's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Utah Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Utah Medical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Utah Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Utah Medical Products. Please utilize our Beneish M Score to check the likelihood of Utah Medical's management manipulating its earnings.
Evaluate Utah Medical's management efficiency
Utah Medical Products has return on total asset (ROA) of 0.0849 % which means that it generated a profit of $0.0849 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1333 %, meaning that it created $0.1333 on every $100 dollars invested by stockholders. Utah Medical's management efficiency ratios could be used to measure how well Utah Medical manages its routine affairs as well as how well it operates its assets and liabilities. At present, Utah Medical's Return On Assets are projected to increase slightly based on the last few years of reporting. At present, Utah Medical's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Assets is expected to grow to 0.95, whereas Non Currrent Assets Other are projected to grow to (0.95).| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 35.36 | 37.13 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | 30.22 | 31.73 | |
| Enterprise Value Over EBITDA | 8.59 | 11.31 | |
| Price Book Value Ratio | 2.38 | 4.37 | |
| Enterprise Value Multiple | 8.59 | 11.31 | |
| Price Fair Value | 2.38 | 4.37 | |
| Enterprise Value | 177.7 M | 92.5 M |
The analysis of Utah Medical's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Utah Medical's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Utah Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield 0.0174 | Forward Dividend Yield 0.0174 | Forward Dividend Rate 1.2 | Beta 0.13 |
Basic technical analysis of Utah Stock
As of the 9th of May, Utah Medical has the Variance of 2.17, risk adjusted performance of (0.05), and Coefficient Of Variation of (1,065). In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Utah Medical Products, as well as the relationship between them. In other words, you can use this information to find out if the company will indeed mirror its model of past prices and volume data, or the prices will eventually revert. We have collected data for thirteen technical drivers for Utah Medical Products, which can be compared to its competition. Please validate Utah Medical Products mean deviation, information ratio, as well as the relationship between the Information Ratio and potential upside to decide if Utah Medical is priced more or less accurately, providing market reflects its prevalent price of 68.99 per share. Given that Utah Medical Products has information ratio of (0.15), we advise you to double-check Utah Medical Products's current market performance to make sure the company can sustain itself at a future point.Utah Medical's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Utah Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Utah Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Utah Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Barbara Payne over two weeks ago Disposition of 1097 shares by Barbara Payne of Utah Medical at 93.7911 subject to Rule 16b-3 | ||
Brian Koopman over a month ago Disposition of 366 shares by Brian Koopman of Utah Medical at 101.88 subject to Rule 16b-3 | ||
Kevin Cornwell over a month ago Disposition of 2401 shares by Kevin Cornwell of Utah Medical at 91.759 subject to Rule 16b-3 | ||
Brian Koopman over three months ago Acquisition by Brian Koopman of 500 shares of Utah Medical subject to Rule 16b-3 | ||
Brian Koopman over six months ago Bona fide gift to Brian Koopman of tradable shares of Utah Medical subject to Section 16 | ||
Paul Richins over six months ago Sale by Paul Richins of 700 shares of Utah Medical | ||
Paul Richins over a year ago Bona fide gift to Paul Richins of 150 shares of Utah Medical subject to Section 16 |
Understand Utah Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Utah Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | 0.4444 | |||
| Mean Deviation | 1.12 | |||
| Coefficient Of Variation | (1,065) | |||
| Standard Deviation | 1.47 | |||
| Variance | 2.17 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.33) | |||
| Treynor Ratio | 0.4344 | |||
| Maximum Drawdown | 7.16 | |||
| Value At Risk | (2.14) | |||
| Potential Upside | 2.36 | |||
| Skewness | (0.23) | |||
| Kurtosis | 1.04 |
| Risk Adjusted Performance | (0.05) | |||
| Market Risk Adjusted Performance | 0.4444 | |||
| Mean Deviation | 1.12 | |||
| Coefficient Of Variation | (1,065) | |||
| Standard Deviation | 1.47 | |||
| Variance | 2.17 | |||
| Information Ratio | (0.15) | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.33) | |||
| Treynor Ratio | 0.4344 | |||
| Maximum Drawdown | 7.16 | |||
| Value At Risk | (2.14) | |||
| Potential Upside | 2.36 | |||
| Skewness | (0.23) | |||
| Kurtosis | 1.04 |
Consider Utah Medical's intraday indicators
Utah Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Utah Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 192.11 | |||
| Daily Balance Of Power | (0.53) | |||
| Rate Of Daily Change | 0.99 | |||
| Day Median Price | 69.04 | |||
| Day Typical Price | 69.02 | |||
| Market Facilitation Index | 1.0E-4 | |||
| Price Action Indicator | (0.29) | |||
| Period Momentum Indicator | (0.48) |
Utah Medical Corporate Filings
8K | 6th of May 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 15th of April 2024 Other Reports | ViewVerify | |
| 10th of April 2024 Other Reports | ViewVerify | |
10K | 26th of March 2024 Annual report required by the U.S. Securities and Exchange Commission (SEC) of a company financial performance | ViewVerify |
Utah Stock media impact
Far too much social signal, news, headlines, and media speculation about Utah Medical that are available to investors today. That information is available publicly through Utah media outlets and privately through word of mouth or via Utah internal channels. However, regardless of the origin, that massive amount of Utah data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Utah Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Utah Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Utah Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Utah Medical alpha.
Utah Medical Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Utah Medical can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Utah Medical without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run CEOs Directory Now
CEOs DirectoryScreen CEOs from public companies around the world |
| All Next | Launch Module |
How to buy Utah Stock?
To provide specific investment advice or recommendations on Utah Medical Products stock, we recommend investors consider the following general factors when evaluating Utah Medical Products. This will help you to make an informed decision on whether to include Utah Medical in one of your diversified portfolios:- Examine Utah Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Utah Medical's leadership team and their track record. Good management can help Utah Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Utah Medical's business and its evolving consumer preferences.
- Compare Utah Medical's performance and market position to its competitors. Analyze how Utah Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Utah Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Utah Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Utah Medical Products stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Utah Medical Products is a good investment.
Already Invested in Utah Medical Products?
The danger of trading Utah Medical Products is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Utah Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Utah Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Utah Medical Products is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Utah Medical Products is a strong investment it is important to analyze Utah Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Utah Medical's future performance. For an informed investment choice regarding Utah Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Utah Medical Products. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Utah Stock analysis
When running Utah Medical's price analysis, check to measure Utah Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Utah Medical is operating at the current time. Most of Utah Medical's value examination focuses on studying past and present price action to predict the probability of Utah Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Utah Medical's price. Additionally, you may evaluate how the addition of Utah Medical to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stocks Directory Find actively traded stocks across global markets |
Is Utah Medical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Utah Medical. If investors know Utah will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Utah Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.06) | Dividend Share 1.19 | Earnings Share 4.51 | Revenue Per Share 13.531 | Quarterly Revenue Growth (0.09) |
The market value of Utah Medical Products is measured differently than its book value, which is the value of Utah that is recorded on the company's balance sheet. Investors also form their own opinion of Utah Medical's value that differs from its market value or its book value, called intrinsic value, which is Utah Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Utah Medical's market value can be influenced by many factors that don't directly affect Utah Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Utah Medical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Utah Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Utah Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.